Summary:
This is a 29 week study for people who have uncontrolled diabetes type 2 diabetes and are taking 20-40 units of basal insulin (lantus, levemir, NPH) and metformin (at least 1500mg/day) - with or without sulfonylurea (glipizide, glyburide, glimeperide). The study consist of 11 office visits and 23 phone visits.
Qualified Participants Must:
Have type 2 diabetes for at least 3 months
Be at least 18 years of age
Be taking diabetic medications for at least 3 months
Not have taken anything else for diabetes for the past 3 month
Not be pregnant or breast feeding
Not be participating in any other research studies
Qualified Participants May Receive:
Physical examinations by qualified physician, blood work, EKGs, and study medication. Qualified participants will also receive up to $1010 (if you complete the whole study)